查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1545519

電刺激設備的全球市場

Electrical Stimulation Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球電刺激設備市場將達到 157 億美元

2023年全球電刺激設備市場預計為92億美元，預計2030年將達到157億美元，2023年至2030年複合年成長率為8.0%。疼痛管理應用是本報告分析的細分市場之一，預計複合年成長率為 8.3%，到分析期結束時將達到 54 億美元。在分析期間，神經病學和運動障礙管理應用領域的複合年成長率預計為 9.5%。

美國市場預計25億美元，中國預計複合年成長率7.4%

預計 2023 年美國電刺激設備市場規模將達 25 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達24億美元，2023-2030年分析期間複合年成長率為7.4%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 7.3% 和 6.4%。在歐洲，德國的複合年成長率預計約為 6.5%。

全球電刺激設備市場－主要趨勢與促進因素總結

電刺激設備如何徹底改變復健和疼痛管理？

電刺激設備正在徹底改變復健、疼痛管理和力量再教育領域。這些設備會向受影響區域發送電脈衝，用於刺激神經和肌肉，從而在各種醫療環境中產生治療效果。經皮神經電刺激（TENS）、功能性電刺激（FES）和神經肌肉電刺激（NMES）等技術可以緩解損傷或神經系統疾病患者的疼痛、減少肌肉萎縮、改善運動功能。透過模仿中樞神經系統的自然運作，這些設備可以激活功能不佳的肌肉，增加血液循環，並釋放內啡肽以減輕疼痛感。這種非侵入性方法對於尋求藥物止痛替代方案或處於手術後恢復期的患者特別有價值，可顯著提高生活品質並加速康復之路。

哪些技術創新正在增強電刺激設備的功能？

電刺激技術的創新重點是提高這些設備的有效性、易用性和可近性。最近的進展包括整合無線技術以允許遠端控制設備、增加用戶便利性並允許更靈活的治療選擇。穿戴式刺激器的開發也取得了重大進展，患者可以在日常生活中使用這些刺激器來提供持續的治療和監測，而不會干擾日常生活。此外，電極設計的改進使設備更加舒適，並且能夠更有效地將電脈衝傳送到目標區域。人工智慧 (AI) 是另一個取得長足進步的領域，其演算法能夠根據使用者身體的即時回饋來調整刺激模式，從而根據個人需求最佳化治療結果。這些技術進步不僅改善了患者的治療效果，也有助於電刺激作為現代醫學的關鍵組成部分的廣泛採用和接受。

電刺激設備如何影響醫療保健的永續性？

電刺激設備透過提供具有成本效益的非藥物治療方案，減少對藥物和侵入性手術的依賴，為醫療保健的永續性做出了重大貢獻。透過使用這些設備控制疼痛和促進肌肉功能，醫療保健提供者可以最大限度地減少鴉片類藥物和其他止痛藥的使用，這些藥物通常價格昂貴，並且具有副作用和潛在的成癮性。此外，透過讓患者家用中管理自己的病情，電刺激可以減少重複就診和長時間住院的需要，從而降低整體醫療成本和資源使用。這種轉變不僅會減輕醫療保健系統的財務負擔，而且使患者能夠更好地控制自己的護理，從而改善整體健康結果和患者滿意度。

推動電刺激設備市場成長的趨勢是什麼？

在幾個主要趨勢的推動下，電刺激設備市場正在經歷強勁成長，這些趨勢包括世界老化、慢性疼痛和神經系統疾病患病率上升以及對非侵入性治療的認知和接受度不斷提高。隨著人口老化，對與老齡化相關的疾病的有效治療的需求不斷成長，這些疾病可以透過電刺激來改善，例如關節炎、肌肉無力和神經退化性疾病。此外，隨著世界慢性疼痛負擔的增加，越來越多的患者和醫療保健專業人員正在尋求非藥物替代療法，刺激了對電刺激設備的需求。技術進步使這些設備更易於使用且更有效，也有助於提高採用率。此外，新興國家醫療保健基礎設施和服務的擴張也為採用這些創新治療方法提供了更多機會。總的來說，這些趨勢凸顯了電刺激在現代醫療保健中不斷擴大的作用及其改善世界各地患者生活的潛力。

受訪企業範例（共18家）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTL Industries, Inc.
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO Global, Inc.
  • Medtronic PLC
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • Zynex Medical

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP11720

Global Electrical Stimulation Devices Market to Reach US$15.7 Billion by 2030

The global market for Electrical Stimulation Devices estimated at US$9.2 Billion in the year 2023, is expected to reach US$15.7 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Pain Management Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Neurological & Movement Disorder Management Application segment is estimated at 9.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.4% CAGR

The Electrical Stimulation Devices market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Electrical Stimulation Devices Market - Key Trends and Drivers Summarized

How Are Electrical Stimulation Devices Revolutionizing Rehabilitation and Pain Management?

Electrical stimulation devices are transforming the fields of rehabilitation, pain management, and muscular retraining. These devices, which deliver electrical pulses to affected areas, are used to stimulate nerves and muscles, providing therapeutic benefits in various medical settings. Techniques such as Transcutaneous Electrical Nerve Stimulation (TENS), Functional Electrical Stimulation (FES), and Neuromuscular Electrical Stimulation (NMES) are widely utilized to alleviate pain, reduce muscle atrophy, and improve motor function in patients with injuries or neurological conditions. By mimicking the natural action of the central nervous system, these devices can activate muscles that are not functioning optimally, enhance blood circulation, and release endorphins to reduce pain sensations. This non-invasive approach is particularly valuable for patients seeking alternatives to pharmaceutical pain relief or those in postoperative recovery, significantly enhancing quality of life and accelerating the path to recovery.

What Innovations Are Enhancing the Functionality of Electrical Stimulation Devices?

Innovation in electrical stimulation technology is focused on enhancing the effectiveness, user-friendliness, and accessibility of these devices. Modern advancements include the integration of wireless technologies, which allow for remote control of the devices, increasing convenience for users and enabling more flexible treatment options. There is also significant progress in developing wearable stimulation devices that patients can use in their everyday lives, providing continuous therapy and monitoring without disrupting daily activities. Moreover, improvements in electrode design have made devices more comfortable and efficient at delivering electrical pulses to the target areas. Artificial intelligence (AI) is another area where substantial strides are being made, with algorithms that can adapt stimulation patterns based on real-time feedback from the user's body, optimizing therapeutic outcomes tailored to individual needs. These technological enhancements not only improve patient outcomes but also contribute to broader adoption and acceptance of electrical stimulation as a critical component of modern medical care.

How Do Electrical Stimulation Devices Impact Healthcare Sustainability?

Electrical stimulation devices contribute significantly to healthcare sustainability by offering cost-effective, non-pharmacological treatment options that reduce dependence on medication and invasive procedures. By managing pain and facilitating muscle function with these devices, healthcare providers can minimize the use of opioids and other pain-relief drugs, which are often expensive and have the potential for side effects and addiction. Additionally, electrical stimulation can reduce the need for repeated medical visits or prolonged hospital stays by enabling patients to manage their conditions at home, thereby decreasing overall healthcare costs and resource use. This shift not only alleviates the financial burden on healthcare systems but also empowers patients with more control over their treatment, leading to better overall health outcomes and patient satisfaction.

What Trends Are Driving Growth in the Electrical Stimulation Devices Market?

The market for electrical stimulation devices is experiencing robust growth driven by several key trends, including the aging global population, the rising prevalence of chronic pain and neurological disorders, and increased awareness and acceptance of non-invasive therapies. As the population ages, there is a higher demand for effective treatments for age-related conditions such as arthritis, muscle weakness, and neurodegenerative diseases, which can be ameliorated through electrical stimulation. Furthermore, as the global burden of chronic pain increases, more patients and healthcare providers are looking for alternative therapies that do not rely on medications, thereby fueling demand for electrical stimulation devices. Advances in technology that make these devices more user-friendly and effective also contribute to their growing adoption. Additionally, the expansion of healthcare infrastructure and services in emerging economies provides further opportunities for the penetration of these innovative therapies. These trends collectively underscore the expanding role of electrical stimulation in contemporary healthcare and its potential to enhance the lives of patients worldwide.

Select Competitors (Total 18 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTL Industries, Inc.
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO Global, Inc.
  • Medtronic PLC
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • Zynex Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Electrical Stimulation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Neurological Disorders Globally Drives Demand for Electrical Stimulation Devices
    • Technological Breakthroughs in Neuromodulation Propel Market Growth
    • Aging Populations Worldwide Expand Addressable Market for Pain Management Therapies
    • Innovations in Wearable Electrical Stimulation Devices Strengthen Business Cases
    • Expanding Insurance Coverage for Rehabilitation Devices Accelerates Market Adoption
    • Market Trends Toward Home-based Therapy and the Rise of Telehealth
    • Increasing Clinical Evidence Supporting the Efficacy of Electrical Stimulation
    • Expanding Application in Veterinary Medicine Opens New Market Avenues
    • Market Dynamics Driven by Increasing Healthcare Expenditure
    • Research Focus on Deep Brain Stimulation and Its Expanding Indications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation (SCS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spinal Cord Stimulation (SCS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Spinal Cord Stimulation (SCS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation (DBS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Deep Brain Stimulation (DBS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Deep Brain Stimulation (DBS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Neurological & Movement Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Neurological & Movement Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Neurological & Movement Disorder Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Musculoskeletal Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Musculoskeletal Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Musculoskeletal Disorder Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Metabolism & GIT Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Metabolism & GIT Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Metabolism & GIT Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Electrical Stimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Electrical Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Electrical Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Electrical Stimulation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Electrical Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION